Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 1/20 | 0.42 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | BACE1 | P56817 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26326216 | 0.86 | AR (0.53) | ARTSHRMAPK1MAPTLMNA | |
| SCHEMBL22182602 | 0.83 | KMT2A (0.51) | NPC1RAB9ATSHRMAPK1MAPT | |
| SCHEMBL12243254 | 0.80 | AR (0.68) | ARPLA2G4BNPC1RAB9ATSHR | |
| SCHEMBL26326569 | 0.80 | SLC6A2 (0.51) | ARTSHRMAPK1MAPTLMNA | |
| SCHEMBL25731814 | 0.79 | MAPK1 (0.64) | TSHRMAPK1LMNAALDH1A1KMT2A | |
| SCHEMBL25731813 | 0.77 | AR (0.63) | ARPLA2G4BNPC1RAB9ATSHR | |
| SCHEMBL6228324 | 0.76 | AR (0.61) | ARTSHRMAPK1MAPTLMNA | |
| SCHEMBL21401353 | 0.76 | PLA2G4B (0.51) | ARPLA2G4BNPC1RAB9ATSHR | |
| SCHEMBL31213834 | 0.75 | AR (0.53) | ARTSHRMAPK1MAPTLMNA | |
| SCHEMBL16314627 | 0.74 | SMN1; SMN2 (0.53) | TSHRMAPTLMNAPOLBNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11768436-B2 | Protective film forming composition having a diol structure | NISSAN CHEMICAL CORPORATION (JP) | 2023-09-26 | — | — | US | disclosed |
| US-11768436-B2 | Protective film forming composition having a diol structure | NISSAN CHEMICAL CORPORATION (JP) | 2023-09-26 | — | — | US | disclosed |
| US-20230187208-A1 | PROTECTIVE FILM-FORMING COMPOSITION CONTAINING DIOL STRUCTURE | NISSAN CHEMICAL CORPORATION (JP) | 2023-06-15 | — | — | US | disclosed |
| US-20230187208-A1 | PROTECTIVE FILM-FORMING COMPOSITION CONTAINING DIOL STRUCTURE | NISSAN CHEMICAL CORPORATION (JP) | 2023-06-15 | — | — | US | disclosed |
| US-20220404706-A1 | CHEMICAL-RESISTANT POLYVALENT CARBOXYLIC ACID-CONTAINING PROTECTIVE FILM | NISSAN CHEMICAL CORPORATION (JP) | 2022-12-22 | — | — | US | disclosed |
| US-20200319561-A1 | PROTECTIVE FILM FORMING COMPOSITION HAVING A DIOL STRUCTURE | NISSAN CHEMICAL CORPORATION (JP) | 2020-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230187208-A1 | PROTECTIVE FILM-FORMING COMPOSITION CONTAINING DIOL STRUCTURE | DSG1, RAD51, CDH1 | AR 1517/4885PLA2G4B 1021/4885NPC1 3940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.